Billerica, MA, United States of America

Mingshi Dai


Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 73(Granted Patents)


Location History:

  • Billerica, MA (US) (2004 - 2009)
  • Lexington, MA (US) (2011)

Company Filing History:


Years Active: 2004-2011

Loading Chart...
6 patents (USPTO):

Title: Mingshi Dai: Innovator in Chemokine Receptor Activity Inhibition

Introduction

Mingshi Dai is a notable inventor based in Billerica, MA (US), recognized for his contributions to the field of pharmaceutical chemistry. He holds a total of six patents, showcasing his innovative approach to developing compounds that target specific biological activities.

Latest Patents

Among his latest patents, Mingshi Dai has developed aryl sulfonamides that serve as inhibitors of chemokine receptor activity. These compounds, described by a general formula, are designed to inhibit CCR8, making them valuable for treating various inflammatory and allergic disorders. The detailed structure of these compounds includes specific definitions for R, X, Z, Ar, n, and other components, which are crucial for their functionality.

Career Highlights

Mingshi Dai has had a significant career, working with prominent companies such as Millennium Pharmaceuticals Limited and Ore Pharmaceuticals Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Mingshi has collaborated with notable colleagues, including Tracy J Jenkins and Bing Guan. These partnerships have likely enhanced his research and innovation efforts in the pharmaceutical field.

Conclusion

Mingshi Dai's work in developing inhibitors for chemokine receptor activity highlights his innovative spirit and dedication to addressing medical challenges. His contributions continue to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…